References
- Hörl W H, Steinhauer H B, Riegel W, Schollmeyer P, Schäfer R M, Heidland A. Effect of different dialyzer membranes on plasma levels of granulocyte elastase. Kidney Int 1988; 33: 90–1
- Salzman E W. Nonthrombogenic surfaces: critical review. Blood 1971; 38: 509–23
- Heimark R L, Kurachi K, Fujikawa K, Davie E W. Surface activation of blood coagulation, fibrinolysis and kinin formation. Nature 1980; 286: 456–560
- Farrell P C, Ward R A, Schindhelm K, Gotch F A. Precise anticoagulation for routine hemodialysis. J Lab Clin Med 1978; 902: 164–76
- Gunnarsson B, Asaba H, Dawidsson S, Wilhelmsson S, Bergstrom J. The effects of three different heparin regimes on heparin concentration in plasma and fibrin formation in dialyzers. Clin Nephrol 1981; 15: 135–42
- Ireland H, Lane D A, Curtis J R. Objective assessment of heparin requirements in humans. J Lab Clin Med 1984; 103: 643–52
- Wilhelmsson S, Kockum C, Kudryk B, Robinson D, Biberfeldt P. Thrombin activity during hemodialysis evaluated by the fibrinopeptid A assay, A comparison between a high and a low dose regime. Thromb Res 1983; 31: 685–9
- Lane D A, Ireland H, Flynn A, Anastassiades E, Curtis J R. Haemodialysis with Low MW Heparin: Dosage requirements for the elimination of extracorporeal fibrin formation. Nephrol Dial Transplant 1986; 1: 179–87
- Anastassiades E G, Lane D A, Flynn A, Curtis J R. Preliminary evaluation of repeated use of a low molecular weight heparin in haemodialysis for chronic renal failure. Proc Eur Dial Trans Assoc 1985; 22: 329–33
- Ljungberg B, Blombäck M, Johnsson H, Lins L E. A single dose of a low molecular weight heparin fragment for anticoagulation during hemodialysis. Clin Nephrol 1987; 27: 31–5
- Schrader J, Rieger J, Muschen H, Stibbe W, Köstering H, Kramer P, Scheler F. Anwendung von niedermolekularem Heparin bei Hämodialysepatienten. Klin Wochenschr 1985; 63: 49–55
- Bick R L. Disseminated intravascular coagulation and related syndroms: Etiology, pathophysiology, diagnosis, and management. Am J Hematol 1978; 5: 265–82
- Feinstein D I. Diagnosis and management of disseminated intravascular coagulation: the role of heparin therapy. Blood 1982; 60: 284–7
- Anderson R. Individual heparin therapy for routine hemodialysis. Dial Transplant 1978; 7: 1007–10
- Hoek J A, Sturk A, ten Cate J W, Lamping R J, Berends F, Borm J JJ. Laboratory and clinical evaluation of an assay of thrombin-antithrombin III complexes in plasma. Clin Chem 1988; 34: 2058–62
- Pelzer H, Schwarz A, Heimburger N. Determination of human thrombin-antithrombin HI complex in plasma with an enzyme-linked immunosorbent assay. Thromb Haemostas 1988; 59: 101–6
- Wiman B, Ranby M. Determination of soluble fibrin in plasma by a rapid and quantitative spectrophotometric assay. Thromb Haemostas 1986; 55: 189–93
- Nossel H L, Yudelman I, Canfield R E, Butler V P, Spandonis K, Wilner G D, Qureshi G D. Measurement of fibrinopeptide A in human blood. J Clin Invest 1974; 54: 43–53
- Stötzer K E, Amiral J, Spanuth E. Neue Methoden zur spezifischen Bestimmung von Fibrinspaltprodukten (D-Dimere). Lab Med 1988; 12: 51–9
- Ireland H, Lane D A, Flynn A, Pegrum A C, Curtis J R. Low molecular weight heparin in haemodialysis for chronic renal failure: dose finding study of CY222. Thromb Haemostas 1988; 59: 240–7
- Teien A N, Lie M, Abildgaard U. Assay of heparin in plasma using a chromogenic substrate for activated factor X. Thromb Res 1976; 8: 413–6
- Vinazzer H. Zur Bestimmung von Heparin im Plasma. Anaesthesist 1979; 28: 299–303
- Gaffney P J. Fibrin fragmentation by plasmin: molecular considerations and their relevance to DIC and thrombosis. Fibrinogen-Recent Biochemical and Medical Aspects, A Henschen, H Graeff, F Lottspeich. W de Gruyter. 1982; 407–23
- Hafter R, Schröck R, von Hugo R, Graeff H. Measurement of crosslinked fibrin derivatives in plasma and ascitic fluid with monoclonal antibodies against D-dimer using El A and Latex test. Scand J Clin Lab Invest 1985; 45: 137–44
- Elms M J, Bunce I H, Bundesen P G, Rylatt D B, Webber A J, Masci P P, Withaker A N. Measurement of crosslinked fibrin degradation productsan immunoassay using monoclonal antibodies. Thromb Haemostas 1983; 50: 591–4
- Rylatt D B, Blake A S, Cottis L E, Massingham D A, Fletcher W A, Masci P P, Whitaker A N, Elms M, Bunce I, Webber A J, Wyatt D, Bundensen P G. An immunoassay for human D-dimer using monoclonal antibodies. Thromb Res 1983; 31: 767–71